Pulmonary hypertension echocardiography or ultrasound
|
Pulmonary Hypertension Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pulmonary hypertension echocardiography or ultrasound On the Web |
|
American Roentgen Ray Society Images of Pulmonary hypertension echocardiography or ultrasound |
|
FDA on Pulmonary hypertension echocardiography or ultrasound |
|
CDC on Pulmonary hypertension echocardiography or ultrasound |
|
Pulmonary hypertension echocardiography or ultrasound in the news |
|
Blogs on Pulmonary hypertension echocardiography or ultrasound |
|
Risk calculators and risk factors for Pulmonary hypertension echocardiography or ultrasound |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Richard Channick, M.D.; Assistant Editor(s)-in-Chief: Ralph Matar
Overview
Echocardiography may demonstrate enlargement of the right chambers with a thickened interventricular septum in patients with pulmonary hypertension. Right ventricular afterload may be suggested by a leftward septal displacement during systole. Pericardial effusions and diminished left ventricular cavity typically portend a dismal prognosis.
Echocardiography
Once pulmonary hypertension is suspected in a patient, a transthoracic echocardiogram should be done to assess right heart functions including:
- Pulmonary arterial pressure
- Tricuspid regurgitation
- Increased velocity of pulmonary valve regurgitation and short acceleration time of right ventricle ejection into the pulmonary artery
- Enlarged right heart chambers
- Abnormal shape and function (displacement) of interventricular septum
- Right ventricular wall hypertrophy
- Dilated main pulmonary artery
- Pericardial effusion
- Doppler echocardiographic index (Tei index or myocardial performance index) which is the sum of both isovolumetric contraction and relaxation intervals, divided by the ejection time
Shown below is a table summarizing the criteria to estimate the likelihood of the presence of PH based on echocardiography findings.[1]
| Likelihood of the Presence of PH | Criteria | Class, Level of Evidence |
| Unlikely | Tricuspid regurgitation velocity ≤2.8 m/s AND Pulmonary artery systolic pressure ≤36 mmHg AND Absence of other echocardiography findings suggestive of PH |
Class I, Level of Evidence B |
| Possible | Tricuspid regurgitation velocity ≤2.8 m/s AND Pulmonary artery systolic pressure 37-50 mmHg AND Presence of other echocardiography findings suggestive of PH |
Class IIa, Level of evidence C |
| Possible | Tricuspid regurgitation velocity 2.9-3,4 m/s AND Pulmonary artery systolic pressure ≤36 mmHg AND Presence or absence of other echocardiography findings suggestive of PH |
Class IIa, Level of Evidence C |
| Likely | Tricuspid regurgitation velocity >3.4 m/s AND Pulmonary artery systolic pressure >50 mmHg AND Presence or absence of other echocardiography findings suggestive of PH |
Class I, Level of evidence B |
Echocardiography plays a pivotal role in the diagnosis of PH due to left heart failure. Echocardiographic findings characteristic of left ventricular diastolic dysfunction are:[2]
- Left atrial enlargement
- Concentric remodeling of the left ventricle
- Left ventricular hypertrophy
- Findings suggestive of increased left ventricular filling pressure
Video showing Top 10 echocardiographic findings in moderate to severe pulmonary hypertension
Disclaimer: Adapted from Billy Cathey RDCS:Pulmonary hypertension 2D findings: {{#ev:youtube|3yOdNyTH07g}} Abbreviations:
- RVE: Right ventricular enlargement
- RVH: Right ventricular hypertrophy
- RAE: Right atrial enlargement
- TR: Tricuspid regurgitation
- PFO: Patent foramen ovale
- RVSP: Right ventricular systolic pressure
- SPAP: Systolic pulmonary artery pressure
- RVOT: Right ventricular outflow tract
- IVC: Inferior vena cava
References
- ↑ Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA; et al. (2009). "Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)". Eur Heart J. 30 (20): 2493–537. doi:10.1093/eurheartj/ehp297. PMID 19713419.
- ↑ Hoeper MM, Barberà JA, Channick RN, Hassoun PM, Lang IM, Manes A; et al. (2009). "Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension". J Am Coll Cardiol. 54 (1 Suppl): S85–96. doi:10.1016/j.jacc.2009.04.008. PMID 19555862.